The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AMERISOURCEBERGEN CORP | COM | 03073E105 | 10,370 | 109,700 | SH | SOLE | 109,700 | 0 | 0 | ||
ANIKA THERAPEUTICS INC | COM | 035255108 | 6,168 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 10,385 | 55,200 | SH | SOLE | 55,200 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 6,784 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
CHARLES RIV LABS INTL INC | COM | 159864107 | 7,102 | 70,212 | SH | SOLE | 70,212 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 6,908 | 97,600 | SH | SOLE | 97,600 | 0 | 0 | ||
IMMUCELL CORP | COM PAR $0.10 | 452525306 | 1,335 | 182,133 | SH | SOLE | 182,133 | 0 | 0 | ||
LABORATORY CORP AMER HLDGS | COM NEW | 50540R409 | 7,060 | 45,800 | SH | SOLE | 45,800 | 0 | 0 | ||
LIGAND PHARMACEUTICALS INC | COM NEW | 53220K504 | 6,823 | 56,200 | SH | SOLE | 56,200 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 10,382 | 63,100 | SH | SOLE | 63,100 | 0 | 0 | ||
PFIZER INC | COM | 717081103 | 6,879 | 204,800 | SH | SOLE | 204,800 | 0 | 0 |